SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ocumetics hits 12-month follow-up in first-in-human lens study

Ocumetics said its first-in-human Group One patients reached the 12-month follow-up milestone in its accommodating intraocular lens study, with results expected shortly.

OTC

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.